Allergan Taytulla Softgels Recall: Contraceptive Tablets Out of Sequence
Allergan recalls physicians' sample Taytulla Softgel Capsules due to contraceptive tablets being out of sequence. This may cause unintended pregnancy. Contact Allergan for details.
Recall notice
Contraceptive Tablets Out of Sequence.
Contact the company
What happened, in plain English
Allergan is recalling physicians' sample Taytulla Softgel Capsules because contraceptive tablets may be out of sequence. This could lead to unintended pregnancy if used incorrectly. Read more at govinfonow.com/recall/40514-allergan-taytulla-softgels-recall-contraceptive-tablets-out-of-sequence.
Source Summary by GovInfoNow · govinfonow.com/recall/40514-allergan-taytulla-softgels-recall-contraceptive-tablets-out-of-sequence · Updated October 7, 2026 · FDA enforcement record: FDA #D-0875-2018
Cite this page
“Allergan Taytulla Softgels Recall: Contraceptive Tablets Out of Sequence.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40514-allergan-taytulla-softgels-recall-contraceptive-tablets-out-of-sequence. Based on FDA recall #D-0875-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0875-2018%22&limit=1).
Why it’s dangerous
The contraceptive tablets in the sample may be out of sequence, meaning they might not work as intended. This could result in unintended pregnancy if the product is used without following the correct sequence.
Who’s affected
Physicians who received this sample product are likely affected. Those using it for contraception without proper sequence may be at risk.
How to tell if you have this one
Check for the product name 'Allergan Taytulla Softgel Capsules', 1 mg/20 mcg, 6x28 blister card, and the lot number 5620706 with expiration 05/19.
- Brand
Allergan- Product
Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample - Not for Sale Distributed by- Category
Drug
What to do — step by step
Check Product Details
Look for the product name, 1 mg/20 mcg, 6x28 blister card, and lot number 5620706 with expiration 05/19.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “US Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 4 years after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0875-2018 (May 24, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0875-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.